Cancer in patients on dialysis for end-stage renal disease: an international collaborative study

@article{Maisonneuve1999CancerIP,
  title={Cancer in patients on dialysis for end-stage renal disease: an international collaborative study},
  author={Patrick Maisonneuve and Lawrence Y.C. Agodoa and Ryszard Gellert and J. H. Stewart and Gheardo Buccianti and Albert B. Lowenfels and Robert A Wolf and Elisabeth Jones and Alex PS Dsiney and Douglas Briggs and Margaret R. E. McCredie and Peter Boyle},
  journal={The Lancet},
  year={1999},
  volume={354},
  pages={93-99}
}
BACKGROUND Previous studies have suggested that the frequency of cancer is higher in patients with end-stage renal disease (ESRD) than in the general population, but have not established whether this increase is confined to certain cancers or to certain categories of ESRD patients. The aim of this study was to examine the risk of cancer in a large cohort of patients treated by dialysis but not transplantation. METHODS We assembled a cohort of 831,804 patients who received dialysis during the… Expand
Epidemiology of cancer in end-stage renal disease dialysis patients: a national cohort study in Taiwan
TLDR
The distribution of site-specific cancer was different between men and women in patients with ESRD on dialysis, and more attention should be paid to teaching dialysis patients how to avoid the well-known cancer risks and carcinogens and individualized regular cancer screenings. Expand
Cancer among end-stage renal disease patients on dialysis.
TLDR
Cancer screening of end-stage renal disease patients on dialysis should be individualised and based on a reasonable life expectancy and transplant candidacy, keeping in mind the competing risk of cardiovascular mortality. Expand
Cancer in Korean patients with end-stage renal disease: A 7-year follow-up
TLDR
A screening program should be necessary for urinary tract cancer in Korean patients with ESRD, and should be emphasized on female patients and patients with non-diabetic E SRD. Expand
Increased cancer risk in patients undergoing dialysis: a population-based cohort study in North-Eastern Italy
TLDR
The elevated risk for de novo malignancies among dialysis patients in the Friuli Venezia Giulia region, north-eastern Italy suggests the need to implement a targeted approach to cancer prevention and control in Dialysis patients. Expand
Association of Dialysis with the Risks of Cancers
TLDR
Dialysis is associated with a higher risk of cancer in patients with end-stage renal disease, however, cancer screening in ESRD population should be a selective approach, based on individual patient health condition and life expectancy. Expand
Increased risk of cancer in chronic dialysis patients: a population-based cohort study in Taiwan.
TLDR
Increased risk of cancer in chronic dialysis patients is confirmed in the Taiwanese population and it is necessary to develop different strategies for cancer screening in chronicdialysis patients among different ethnicities. Expand
Cancer Incidence and Mortality in Chronic Dialysis Population: A Multicenter Cohort Study
TLDR
The findings of substantially increased risks in young patients, particularly in relation to kidney cancer, suggest that a more individualized approach to cancer screening in chronic dialysis patients can be adopted. Expand
Cancer Incidence and Mortality in Chronic Dialysis Population: A Multicenter Cohort Study
Background: Different studies in the past have shown that the risk of cancer development is increased in chronic dialysis patients. However, data concerning the cancer risk in Asian dialysis patientsExpand
Is there different risk of cancer among end‐stage renal disease patients undergoing hemodialysis and peritoneal dialysis?
Cancer is a global issue in recent decade. Despite this alarming increase in the incidence of cancer, to date, whether the risk of developing cancer differs among peritoneal dialysis (PD) andExpand
Increased risk of urothelial cancer in young and middle aged patients with end-stage renal disease.
TLDR
Patients with ESRD are at increased risk for UC in Taiwan, especially women age 50 years and younger, and early and lifelong surveillance of UC is recommended after diagnosis of E SRD. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 30 REFERENCES
Neoplasms in dialysis patients: a population-based study.
Cancer incidence was assessed in 4,161 end-stage renal disease (ESRD) patients on dialysis to determine whether there was any excess risk of cancer in this population. Records from the MichiganExpand
Cancer among patients on renal replacement therapy: A population‐based survey in Lombardy, Italy
TLDR
The results indicate an excess of renal‐cell and liver carcinomas and lymphomas in patients receiving RRT and highlight the necessity of careful follow‐up and awareness of these associations, together with the need for early detection of such tumours. Expand
Cancer in patients receiving long-term dialysis treatment.
TLDR
A significantly elevated risk of non-Hodgkin's lymphoma among patients with chronic glomerulonephritis accounted for the excess observed in the total series, raising the possibility of factors specific to this disease. Expand
Evidence for increased cancer deaths in chronic dialysis patients.
  • K. Iseki, A. Osawa, K. Fukiyama
  • Medicine
  • American journal of kidney diseases : the official journal of the National Kidney Foundation
  • 1993
TLDR
The proportion of patients with colon cancer (both sexes) and cancer of the uterus and breast (females) was higher in the dialysis patients than in the general population, and the relative risk of death from cancer in Dialysis patients was significantly increased. Expand
The Risk of Cancer for Patients on Dialysis: A Review
TLDR
This review will summarize the studies that have been conducted to discern the risk of cancer in dialysis patients and the issue of monitoring this patient population for cancer will be addressed. Expand
Ten-year prospective study on the development of renal cell carcinoma in dialysis patients.
TLDR
The prospective study results suggest that both the incidence and prevalence of renal cell carcinoma in dialysis patients is high, and major complications of acquired renal cystic disease seem to occur predominantly in males. Expand
Cost-effectiveness of cancer screening in end-stage renal disease.
TLDR
Routine cancer screening in the population with ESRD is a relatively inefficient allocation of financial resources, and direction of funds toward improving the quality of dialysis could attain such an objective at substantially lower cost. Expand
Renal cell carcinoma in uremic acquired renal cystic disease: Incidence, detection, and management
TLDR
Annual imaging of the native kidneys of all dialysis patients is not justified because it has not been shown to have a significant effect on patient outcome, and Screening may, however, be useful in selected patients with good general medical conditions and who have known risk factors for renal carcinoma. Expand
Incidence and mortality patterns of malignancy and factors affecting the risk of malignancy in dialysis patients.
TLDR
A slight to moderate overall increase in the risk of malignancy and a widely differing risk ratio ofmalignancy by organ involved, sex, age, hospital group, epidemiological index and length of dialysis treatment in a large single racial population of maintenance dialysis patients is demonstrated. Expand
Malignancies after renal transplantation: the EDTA-ERA registry experience. European Dialysis and Transplantation Association-European Renal Association.
  • F. Brunner, P. Landais, N. Selwood
  • Medicine
  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 1995
TLDR
Survival after diagnosis of cancer at the most frequent sites, such as bronchopulmonary, breast, oesophagogastric and colorectal cancer, did not differ between non-grafted patient groups on dialysis and those who developed the tumour while carrying a functioning renal transplant. Expand
...
1
2
3
...